-
John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients
van Kempen, Z. L. E., Leurs, C. E., de Vries, A., Vennegoor, A., Rispens, T., Wattjes, M. P. & Killestein, J., 1 Sept 2017, In: European journal of neurology. 24, 9, p. 1196-1199 4 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations
van Kempen, Z. L. E., Leurs, C. E., Vennegoor, A., Wattjes, M. P., Rispens, T., Uitdehaag, B. M. J. & Killestein, J., 1 Jun 2017, In: MULTIPLE SCLEROSIS JOURNAL. 23, 7, p. 995-999 5 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance
Wijburg, M. T., Witte, B. I., Vennegoor, A., Roosendaal, S. D., Sanchez, E., Liu, Y., Martins Jarnalo, C. O., Uitdehaag, B. M. J., Barkhof, F., Killestein, J. & Wattjes, M. P., Oct 2016, In: Journal of neurology, neurosurgery, and psychiatry. 87, 10, p. 1138-1145Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
